Markets:

Overview

News

Currencies

International

Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

8.150 -0.300 (-3.55%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

66 67 Next >

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Europe Approves Novavax's COVID-19 Vaccine Booster For Adults ↗

September 12, 2022

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 22, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

Here Are Novavax's U.S. Vaccination Numbers — And They're Bleak ↗

September 22, 2022

In the U.S., Novavax is going after the 10% of unvaccinated adults.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2022 ↗

September 22, 2022

Upgrades

Via Benzinga

What Is Going on With Accenture (ACN) Stock Today? ↗

September 22, 2022

Accenture (ACN) stock is on the move Thursday after releasing a positive earnings report and announcing a new acquisition.

Via InvestorPlace

Novavax Price Target Cut By Around 80%, Plus This Analyst Predicts $129 For NIKE ↗

September 22, 2022

Morgan Stanley cut the price target for NIKE, Inc. (NYSE: NKE) from $149 to $129. NIKE shares fell 0.6% to $99.20 on Thursday.

Via Benzinga

Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement ↗

September 22, 2022

Spero Therapeutics (SPRO) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (GSK).

Via InvestorPlace

Why Is Novavax (NVAX) Stock Falling Today? ↗

September 22, 2022

Novavax still has cash, but it needs to get approval for another vaccine if NVAX stock is to be worth buying again.

Via InvestorPlace

Why Novavax Stock Is Trading Lower Today ↗

September 22, 2022

Novavax Inc (NASDAQ: NVAX) shares are trading lower Thursday following bearish analyst coverage from JPMorgan.

Via Benzinga

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗

September 22, 2022

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem...

Via Benzinga

US Stock Futures Rise Following Wednesday's Plunge ↗

September 22, 2022

Pre-open movers

Via Benzinga

Novavax Remains a Risk-On Stock in a Risk-Off Market

September 22, 2022

NVAX is a risk-on stock at a time investors are turning to risk-off assets. This article looks to see if Novavax still presents an opportunity for investors

Via MarketBeat

Topics Earnings

These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗

September 20, 2022

We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022.

Via Talk Markets

Nikola, Super Micro Computer And Other Big Losers From Monday ↗

September 20, 2022

U.S. stocks closed higher with the Dow Jones gaining around 197 points on Monday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today? ↗

September 19, 2022

Vaccine stocks are taking it on the chin following President Joe Biden's comments that the "pandemic is over." What now?

Via InvestorPlace

Why BioNTech, Moderna And Novavax Shares Are Diving ↗

September 19, 2022

BioNTech SE - ADR (NASDAQ: BNTX), Moderna Inc (NASDAQ: MRNA) and Novavax, Inc. (NASDAQ: NVAX) are all trading lower during Mo

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 15, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

September 13, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary ↗

September 12, 2022

Via Benzinga

Recap Of Friday's Biotech Catalysts - End Of the Day Summary ↗

September 02, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

September 07, 2022

On Wednesday, 297 companies achieved new lows for the year.

Via Benzinga

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary ↗

September 01, 2022

Via Benzinga

What Is Going on With Vaxart (VXRT) Stock Today? ↗

September 01, 2022

Vaxart released encouraging results for its oral Covid-19 vaccine, though sentiment for VXRT stock presently remains mixed.

Via InvestorPlace

Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines ↗

September 01, 2022

Health Canada has approved Moderna Inc's (NASDAQ:

Via Benzinga

Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash... ↗

September 01, 2022

Wall Street Journal

Via Benzinga

HP, Ambarella, Bed Bath & Beyond And Other Big Losers From Wednesday ↗

September 01, 2022

U.S. stocks closed lower with the Dow Jones dropping around 280 points on Wednesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Is Novavax (NVAX) Stock Down Today? ↗

August 31, 2022

Pfizer and Moderna received FDA approval for their omicron-specific booster. NVAX stock is hitting new 52-week lows in response.

Via InvestorPlace

Why Novavax Shares Are Getting Hammered After Moderna, Pfizer And BioNTech News ↗

August 31, 2022

Novavax, Inc. (NASDAQ: NVAX) shares are trading lower by 6.76% to $32.84 Wednesday afternoon in possible reaction to competitor Moderna Inc (NASDAQ: MRNA) receiving FDA authorization for emergency use...

Via Benzinga

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

66 67 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.